Cross-resistance of dideoxycytidine-resistant cell lines to azidothymidine

Biochemical Pharmacology

Volumn 58, Issue 10, 1999, Pages 1603-1608

  Agarwal, Ram P ^a   Wang, Wei ^a   Yo, Peggy ^a   Han, Tieran ^a   Fernandez, Marilyn ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

2',3' Dideoxycytidine; Azidothymidine; Cellular resistance; ddC AZT cross resistance; Reverse transcriptase inhibitors

Indexed keywords

RNA DIRECTED DNA POLYMERASE; TRIFLUOPERAZINE; VERAPAMIL; ZALCITABINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL;

ANTI-HIV AGENTS; CELL DIVISION; CELLS, CULTURED; DNA; DRUG RESISTANCE, MULTIPLE; GENES, MDR; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; NUCLEOSIDES; REVERSE TRANSCRIPTASE INHIBITORS; THYMIDINE KINASE; U937 CELLS; ZALCITABINE; ZIDOVUDINE;

EID: 0032831894     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00246-4     Document Type: Article

References (23)

1. De Clercq E. Antiviral therapy for human immunodeficiency virus infections. Clin Microbiol Rev. 8:1995;200-239.
2. Gao Q., Gu Z., Hiscott J., Dionne G., Wainberg M.A. Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2′,3′-dideoxycytidine and 2′,3′-dideoxy-3′-thiacytidine. Antimicrob Agents Chemother. 37:1993;130-133.
3. Larder BA, Kohli A, Bloor S, Kemp SD, Harrigan PR, Schooley RT, Lang JM, Pennington KN and St. Clair MH and The Protocol 34,225-02 Collaborative Group, Human immunodeficiency virus type 1 drug susceptibility during zidovudine (AZT) monotherapy compared with AZT plus 2′,3′-dideoxyinosine or AZT plus 2′,3′-dideoxycytidine combination therapy. J Virol 70: 5922-5929, 1996.
4. Magnani M, Gazzanelli G, Brandi G, Casabianca A, Fraternale A, Chiarantini L and Rossi L, 2′,3′-Dideoxycytidine induced drug resistance in human cells. Life Sci 57: 881-887, 1995.
5. Wu S, Liu X, Solorzano MM, Kwock R and Avramis VI, Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5′ end of human TK gene. J Acquir Immune Defic Syndr Hum Retrovirol 8: 1-9, 1995.
6. Martin J.L., Brown C.E., Matthews-Davis N., Reardon J.E. Effect of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob Agents Chemother. 38:1994;2743-2749.
7. Rustum YM, Metabolism and intracellular retention of 1-β-D-arabinofuranosylcytosine as predictors of response of animal tumors. Cancer Res 38: 543-549, 1978.
8. Plunkett W, Benjamin RS, Keating MI and Freireich EJ, Modulation of 9-β-D-arabinofuranosyladenine 5′-triphosphate and deoxyadenosine triphosphate in leukemia cells by 2′-deoxycoformycin during therapy with 9-β-D-arabinofuranosyladenine. Cancer Res 42: 2092-2096, 1982.
9. Antonelli G, Turriziani O, Cianfriglia M, Riva E, Dong G, Fattorossi A and Dianzani F, Resistance of HIV-1 to AZT might also involve the cellular expression of multidrug resistance P-glycoprotein. AIDS Res Hum Retroviruses 8: 1839-1844, 1992.
10. Agarwal RP, Wang W and Yo P, Characteristics of 2′,3′-dideoxycytidine (ddC) and arabinosylcytosine (ara-C) resistance in a human lymphocytic cell line. Proc Am Assoc Cancer Res 39: 216, 1998.
11. Agarwal R.P., Mian A.M. Thymidine and zidovudine metabolism in chronically zidovudine-exposed cells in vitro. Biochem Pharmacol. 42:1991;905-911.
12. Krishan A, Sauerteig A, Andritsch I and Wellham L, Flow cytometric analysis of the multiple drug resistance phenotype. Leukemia 11: 1138-1146, 1997.
13. Magnani M, Bradi G, Casabianca A, Fraternale A, Schiavano GF, Rossi L and Chiarantini L, 2′,3′-Dideoxycytidine metabolism in a new drug-resistant cell line. Biochem J 312: 115-123, 1995.
14. Balzarini J, Pauwels R, Baba M, Herdewijn P, De Clercq E, Broder S and Johns D, The in vitro anti-retrovirus activity, and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxycytidine are highly dependent on the cell species. Biochem Pharmacol 37: 897-903, 1988.
15. Furman PA, Fyfe JA, St. Clair MH, Weinhold K, Rideout JL, Freeman GA, Lehrman SN, Bolognesi DP, Broder S, Mitsuya H and Barry DW, Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci USA 83: 8333-8337, 1986.
16. Tornevik Y, Ullman B, Balzarini J, Wahren B and Eriksson S, Cytotoxicity of 3′-azido-3′-deoxythymidine correlates with 3′-azidothymidine-5′-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3′-azidothymidine-5′-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells. Biochem Pharmacol 49: 829-837, 1995.
17. Zimmerman TP, Mahony WB and Prus KL, 3′-Azido-3′-deoxythymidine: An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by non-facilitated diffusion. J Biol Chem 262: 5748-5754, 1987.
18. Bhalla K, Nayak R and Grant S, Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-β-D-arabinofuranosylcytosine. Cancer Res 44: 5029-5037, 1984.
19. Cheng YC, Domin B and Lee LS, Human deoxycytidine kinase: Purification and characterization of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia patients. Biochim Biophys Acta 481: 481-492, 1977.
20. Carson D.A., Wasson D.B., Kaye J., Ullman B., Martin D.W. Jr, Robins R.K., Montgomery J.A. Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo. Proc Natl Acad Sci USA. 77:1980;6865-6869.
21. Eriksson S, Kierdaszuk B, Munch-Peterson B, Oberg B and Johansson NG, Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. Biochem Biophys Res Commun 176: 586-592, 1991.
22. Johansson M, Brismar S and Karlsson A, Human deoxycytidine kinase is located in the cell nucleus. Proc Natl Acad Sci USA 94: 11941-11945, 1997.
23. Arner ESJ, Spasokoukotskaja T and Eriksson S, Selective assay for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. Biochem Biophys Res Commun 188: 712-718, 1992.